Showing 1 to 2 of 2 results


Australian Weight Loss Drug Users Report Liver Issues
Dozens of Australians using weight-loss injections Wegovy, Ozempic, and Mounjaro have reported liver problems, including hepatitis, prompting a warning from experts for regular GP check-ups; three cases linked to semaglutide were reported to the TGA.
Australian Weight Loss Drug Users Report Liver Issues
Dozens of Australians using weight-loss injections Wegovy, Ozempic, and Mounjaro have reported liver problems, including hepatitis, prompting a warning from experts for regular GP check-ups; three cases linked to semaglutide were reported to the TGA.
Progress
44% Bias Score

FDA Issues Black Box Warning for Menopausal Hot Flash Drug Veozah
The FDA issued a black-box warning for Veozah, a non-hormonal drug treating menopausal hot flashes, due to rare but serious liver injury risk, mandating increased blood tests and immediate treatment cessation upon symptom onset; nearly 29,000 patients used it in May 2024.

FDA Issues Black Box Warning for Menopausal Hot Flash Drug Veozah
The FDA issued a black-box warning for Veozah, a non-hormonal drug treating menopausal hot flashes, due to rare but serious liver injury risk, mandating increased blood tests and immediate treatment cessation upon symptom onset; nearly 29,000 patients used it in May 2024.
Progress
32% Bias Score
Showing 1 to 2 of 2 results